Eyeing an expected leap in demand for contrast media—used in X-rays, CT scans and more—GE HealthCare is upping its stake in the Emerald Isle. | GE HealthCare is pumping $138 million into its ...

GE HealthCare invests $138 million in Cork, Ireland manufacturing facility to address increasing contrast media demand ...

In its latest health check for the Irish economy, aptly named “Dodging Bullets,” Dublin-based broker Goodbody warned Ireland ...

The US could be the beneficiary of a potential blanket ban on the use of PFAS, better known as ‘forever chemicals’.

Poolbeg Pharma, the clinical-stage biopharmaceutical ... Shares in Hookipa, where Irish life sciences industry veteran Julie O’Neill is chairperson, slumped by almost 76 per cent in 2023 as ...

Photo: Getty Leading pharmaceutical and IT companies have said they will quit Ireland if a proposed ban on so-called forever chemicals is introduced. Pfizer, Intel and other major employers are ...

Robert F. Kennedy Jr. accused Bernie Sanders of receiving money from Big Pharma when he ran for President in 2020 during a heated exchange in Kennedy's second day of questioning. Sanders denied the ...

Bank of Ireland has revised its GDP forecast for the Irish economy this year to 4.3%, on the back of stronger data in the ...

For further information regarding Insider events, please use the contact details below: ...

to merge with Nasdaq-listed peer Hookipa Pharma has secured backing from a major shareholder in the target company. Irish-based, but London-listed, Poolbeg said on Tuesday that US biopharma giant ...

GE HealthCare has announced a €132m investment to expand its facility in Cork where they manufacture contrast media - ...

US biopharmaceuticals giant Gilead has thrown its weight behind a potential merger of Ireland’s Poolbeg Pharma and Austria based Hookpia. Gilead is a significant shareholder in Hookpia as well ...